UCT-Masi
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gill, Katherine
Sisonke Boost, NCT05148845: Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Recruiting
3b
500000
RoW
Booster vaccine
Wits Health Consortium (Pty) Ltd, National Department of Health of South Africa, National Institute of Communicable Diseases - NICD, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, Fred Hutchinson Cancer Center, Hutchinson Center Research Institute of South Africa (HCRISA), Janssen Vaccines & Prevention B.V., Bio Analytical Research Corporation, Dis-Chem Pharmacy, BioVac, Biocair, Right to Care, Clinical Laboratory Services, Institute of Infectious Disease and Molecular Medicine
SARS CoV 2 Infection
01/22
06/23
NCT03959527 / 2019-000990-22: Zoliflodacin in Uncomplicated Gonorrhoea

Completed
3
1011
Europe, US, RoW
zoliflodacin, ceftriaxone, azithromycin
Global Antibiotics Research and Development Partnership
Gonorrhea
08/23
09/23
NCT06446752: BIYELA - Bexsero Immunisation in Young Women in Africa

Not yet recruiting
3
1100
RoW
Bexsero, 4MenB-4C, Placebo, Saline
University of Washington, Bill and Melinda Gates Foundation, University of Witwatersrand, South Africa
Gonorrhea, Gonorrhea of Pharynx, Gonorrhea of Anus, Gonorrhea of Cervix
05/26
08/26
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

Completed
N/A
3087
RoW
PrEP, Truvada
University of Washington, Bill and Melinda Gates Foundation
HIV Infections
08/23
08/23
SAMURAI, NCT05139563: South African Male User Research on Acceptability of Implants and Injections

Active, not recruiting
N/A
184
RoW
Placebo injection: Intralipid 20% fat emulsion, Placebo implant
RTI International
Acceptability
08/24
10/24

Download Options